Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer



Rating:

Share or cite this content

Citations should be made in the following way:
H. De Koning (Rotterdam, Netherlands). Is CT-based screening for lung cancer finally ready for prime time?. Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer

Member's Comments

No comment yet.

Related content which might interest you: CT screening for lung cancer: is it ready for prime time yet or how to enhance pre-test probability? Source: International Congress 2017 – The latest in lung cancer Year: 2017 Our diagnostic time for lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 322s Year: 2005 Avoiding overdiagnosis in lung cancer screening: the volume doubling time strategy Source: Eur Respir J 2013; 42: 1459-1463 Year: 2013 An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Source: Annual Congress 2006 - MP11 - An abnormal CT, now what: issues in the diagnosis and management of a patient with a potential lung cancer Year: 2006 Does a straight-to-CT pathway improve lung cancer patient waiting times? Source: Annual Congress 2008 - Treatment of thoracic tumours Year: 2008 Breath biomarkers for lung cancer detection: ready for use by the pulmonologist? Source: Annual Congress 2012 - PG18 Recent evolutions in screening and early diagnosis of lung cancer Year: 2012 Tissue is the issue and beyond: proper sampling for diagnosis and staging of lung cancer by chest physicians as well as its alternatives Source: International Congress 2019 – PG1 Lung cancer: the key multidisciplinary approach Year: 2019 Effect of a fast track CT pathway on diagnostic and treatment waiting times in lung cancer patients Source: International Congress 2019 – Diagnosis of lung cancer Year: 2019 Why can initial treatment of localised lung cancer fail? Source: Annual Congress 2007 - Recurrence of lung cancer following resection with curative intent Year: 2007 Pushing the limits, real benefit for the patient ? – a curative treatment approach in an unfit lung cancer patient Source: International Congress 2017 – GR2 Lung Cancer Grand Round Year: 2017 Factors determining early adherence to a lung cancer screening protocol Source: Eur Respir J 2007; 30: 532-537 Year: 2007 Tumour tissue sampling for lung cancer management in the era of personalised therapy: what is good enough for molecular testing? Source: Eur Respir J 2014; 44: 1011-1022 Year: 2014 The ALA/ATS implementation guide on lung cancer screening Source: International Congress 2018 – Imminent global problems in lung cancer require joint action: time for an international alliance! Year: 2018 Nurse led lung cancer diagnostic/supportive follow up clinic;a different approach to optimise lung cancer pathway Source: International Congress 2018 – The many facets of respiratory nursing Year: 2018 Towards personalized lung cancer CT screening in Europe Source: Virtual Congress 2020 – Screening and imaging in lung cancer Year: 2020 The chest physician as the lung cancer patient’s guide: defining the role of the modern day chest physician throughout the lung cancer continuum Source: International Congress 2017 – PG1 Re-defining the role of chest physicians in lung cancer: new opportunities in diagnostics and therapy Year: 2017 Targeted therapies for lung cancer: how did the game begin? Source: Breathe 2016; 12: 177-179 Year: 2016 Management of incidental nodules in lung cancer screening: ready for prime-time? Source: Breathe, 15 (4) 346; 10.1183/20734735.0247-2019 Year: 2019